Nibrozetone has promising neuroprotective effects in Parkinson's disease (PD) animal models, according to a study released today at the International Congress of Parkinson's Disease and Movement ...
The competition in follicular lymphoma is rapidly intensifying, with three CAR-T therapies and three bispecific antibodies now approved for relapsed or refractory patients. As both classes of ...
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...